NCT00452777 - Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain | Biotech Hunter

Enrollment

193

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2008

Conditions

Diabetic Neuropathic Pain

Interventions

DRUG

BVT.115959

DRUG

Placebo

Trial Locations (20)

Biovitrum investigational site, České Budějovice

Biovitrum investigational site, Litoměřice

Biovitrum investigational site, Pilsen

Biovitrum investigational site, Prague

Biovitrum Investigational Site, Bad Kreuznach

Biovitrum Investigational Site, Berlin

Biovitrum Investigational Site, Dortmund

Biovitrum Investigational Site, Gelsenkirchen

Biovitrum Investigational Site, Hamburg

Biovitrum Investigational Site, Mainz

Biovitrum Investigational Site, Mannheim

Biovitrum Investigational Site, Neumünster

Biovitrum Investigational Site, Bloemfontein

Biovitrum Investigational Site, Durban

Biovitrum Investigational Site, Kenilworth

Biovitrum Investigational Site, Kraaifontein

Biovitrum Investigational Site, Polokwane

Biovitrum Investigational Site, Pretoria

Biovitrum Investigational Site, Somerset West

Biovitrum Investigational Site, Wynberg